Viracta Therapeutics, Inc. (VIRX)
OTCMKTS
· Delayed Price · Currency is USD
0.0165
-0.0038 (-18.72%)
Apr 29, 2025, 2:09 PM EDT
Viracta Therapeutics Market Cap
Viracta Therapeutics has a market cap or net worth of $655.78 thousand as of April 29, 2025. Its market cap has decreased by -98.55% in one year.
Market Cap
655.78K
Enterprise Value
-3.57M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since February 25, 2021, Viracta Therapeutics's market cap has decreased from 8.68M to 655.78K, a decrease of -92.45%. That is a compound annual growth rate of -46.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2025 | 655.78K | -89.75% |
| Dec 31, 2024 | 6.39M | -70.95% |
| Dec 29, 2023 | 22.02M | -60.52% |
| Dec 30, 2022 | 55.77M | -59.05% |
| Dec 31, 2021 | 136.19M | 1,468.41% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.63B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 746.57M |
| Glass House Brands | 500.84M |
| Elite Pharmaceuticals | 450.22M |
| Northwest Biotherapeutics | 443.51M |
| CytoDyn | 284.32M |
| BioStem Technologies | 245.41M |